Weight-loss drugs: Who, and what, are they good for?
Extraordinary demand, and high prices, for powerful weight-loss drugs will keep them out of reach in the coming year for many patients who are likely to benefit.
Extraordinary demand, and high prices, for powerful weight-loss drugs will keep them out of reach in the coming year for many patients who are likely to benefit.
Enfamil is recalling its Nutramigen A+ LGG Hypoallergenic Infant Formula over possible bacterial contamination with Cronobacter sakazakii.
A new study shows a low-cost plant-based drug may be more effective than nicotine replacement therapy for people trying to quit smoking.